ResearcherJianghan UniversityActive in the last 2 years

Feng Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6360-4384; OpenAlex author ID A5001202250. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Research progress in diagnosis and treatment of pancreatic cancer with mismatch repair and microsatellite instability. Last author DOI 10.1007/s12094-025-04214-3 ↗
CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STAT3 Pathway. Co-author DOI 10.1002/cam4.71126 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hang Yin · 2 shared papers, 2025–2026 · strength 0.61
- Paper Research progress in diagnosis and treatment of pancreatic cancer with mismatch repair and microsatellite instability. DOI 10.1007/s12094-025-04214-3 ↗
- Paper CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STA… DOI 10.1002/cam4.71126 ↗
Chunzhao Yu · 1 shared paper, 2025 · strength 0.26
- Paper CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STA… DOI 10.1002/cam4.71126 ↗
Yue Pan · 1 shared paper, 2025 · strength 0.26
- Paper CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STA… DOI 10.1002/cam4.71126 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.